Literature DB >> 646989

Mechanism of coumarin action: significance of vitamin K epoxide reductase inhibition.

D S Whitlon, J A Sadowski, J W Suttie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 646989     DOI： 10.1021/bi00601a003

Source DB:  PubMed          Journal:  Biochemistry        ISSN： 0006-2960            Impact factor:   3.162


× No keyword cloud information.
  72 in total

1.  r-VKORC1 expression in factor IX BHK cells increases the extent of factor IX carboxylation but is limited by saturation of another carboxylation component or by a shift in the rate-limiting step.

Authors:  Kevin W Hallgren; Wen Qian; Anna V Yakubenko; Kurt W Runge; Kathleen L Berkner
Journal:  Biochemistry       Date:  2006-05-02       Impact factor: 3.162

Review 2.  Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Walter Ageno; Alexander S Gallus; Ann Wittkowsky; Mark Crowther; Elaine M Hylek; Gualtiero Palareti
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  [Role of vitamin K antagonists from a hepatologist's point of view].

Authors:  G Kneiseler; A Canbay; G Gerken
Journal:  Herz       Date:  2012-06       Impact factor: 1.443

4.  Novel insight into the mechanism of the vitamin K oxidoreductase (VKOR): electron relay through Cys43 and Cys51 reduces VKOR to allow vitamin K reduction and facilitation of vitamin K-dependent protein carboxylation.

Authors:  Mark A Rishavy; Aisulu Usubalieva; Kevin W Hallgren; Kathleen L Berkner
Journal:  J Biol Chem       Date:  2010-10-26       Impact factor: 5.157

5.  Vitamin K antagonism of coumarin anticoagulation. A dehydrogenase pathway in rat liver is responsible for the antagonistic effect.

Authors:  R Wallin
Journal:  Biochem J       Date:  1986-06-15       Impact factor: 3.857

Review 6.  Vitamin K and hepatocellular carcinoma: The basic and clinic.

Authors:  Xia Jinghe; Toshihiko Mizuta; Iwata Ozaki
Journal:  World J Clin Cases       Date:  2015-09-16       Impact factor: 1.337

Review 7.  The use of novel oral anticoagulants for thromboprophylaxis after elective major orthopedic surgery.

Authors:  Saleh Rachidi; Ehab Saad Aldin; Charles Greenberg; Barton Sachs; Michael Streiff; Amer M Zeidan
Journal:  Expert Rev Hematol       Date:  2013-12       Impact factor: 2.929

8.  Synthesis and biological activity of the novel indanedione anticoagulant rodenticides containing fluorine.

Authors:  Feng Chen; Liping Liu; Zengguo Bai; Tianhua Zhang; Keke Zhao
Journal:  Bioengineered       Date:  2016-10-19       Impact factor: 3.269

9.  Impact of preemptive warfarin dose reduction on anticoagulation after initiation of trimethoprim-sulfamethoxazole or levofloxacin.

Authors:  Abrar Ahmed; John C Stephens; Carol A Kaus; William P Fay
Journal:  J Thromb Thrombolysis       Date:  2007-11-06       Impact factor: 2.300

10.  No strict coupling of vitamin K1 (2-methyl-3-phytyl-1,4-naphthoquinone)-dependent carboxylation and vitamin K1 epoxidation in detergent-solubilized microsomal fractions from rat liver.

Authors:  R Wallin
Journal:  Biochem J       Date:  1979-03-15       Impact factor: 3.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.